IL1B and Schnitzler syndrome: Finally, in Schnitzler syndrome, a rare auto-inflammatory disease that often presents with urticarial rash, fever, lymphadenopathy, musculoskeletal pain, and thrombosis and that is attributed to cytokine dysregulation involving IL-1β and the inflammasome pathway, there is evidence that blocking IL-1 can lead to significant disease control [170].